Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/Core EBITDA

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   EV/Core EBITDA(x) 5.752.905.004.895.34

What is the latest EV/Core EBITDA ratio of VENUS REMEDIES ?

The latest EV/Core EBITDA ratio of VENUS REMEDIES is 5.75 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar20245.75
Mar20232.90
Mar20225.00
Mar20214.89
Mar20205.34

How is EV/Core EBITDA of VENUS REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 5.75
98.28
Mar2023 2.9
-42.00
Mar2022 5
2.25
Mar2021 4.89
-8.43
Mar2020 5.34 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/Core EBITDA ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹471.3 Cr 18.3% 16.6% -10.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,084.0 Cr -0% -4.6% 18.9% Stock Analytics
DIVIS LABORATORIES ₹162,384.0 Cr 8.8% 5.1% 64.4% Stock Analytics
CIPLA ₹118,853.0 Cr 2.4% -1.1% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,143.0 Cr 2.6% -9.9% -0.4% Stock Analytics
ZYDUS LIFESCIENCES ₹101,459.0 Cr 3.6% -0.1% 22.7% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

18.3%

16.6%

-10.2%

SENSEX

0.7%

-0.1%

8.8%


You may also like the below Video Courses